In collaboration with AstraZeneca and Chalmers Industriteknik, Nanolyze will power their technology with AI to improve performance and ease of use. This will broaden the spectrum of researchers in pharmaceutical companies who can make use of the Nanolyze technology to speed up development processes and to develop more efficient and precise therapies based on the emerging field of nanomedicine. The initiation of this project is a direct result of Nanolyze being strategically located within the AstraZeneca BioVentureHub.

Read More